EPHA2, similarly to its role in kidney cancer, seems to promote TCC development, as it exhibited low expression in normal urothelial cells and was highly expressed in advancing stages of bladder cancer [72]. This evidence concerns the gene EPHA2 and tarsal-carpal coalition syndrome.